Picton Mahoney Asset Management’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Picton Mahoney Asset Management’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-203,574	Closed	-$2.09M	–	670
2022 Q4	$2.09M	Hold	203,574	–	–	0.1%	255
2022 Q3	$2.05M	Buy	203,574 +3,574	+2%	+$35.9K	0.07%	284
2022 Q2	$2M	Hold	200,000	–	–	0.08%	363
2022 Q1	$2M	Buy	+200,000	New	+$1.99M	0.07%	359

Other funds holding IQMD

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return

Picton Mahoney Asset Management's IQMD Position: Q1 2023 in Review

Picton Mahoney Asset Management sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q1 2023, closing a stake of 203,574 shares — an estimated $2.09M sold.

Picton Mahoney Asset Management first reported a position in IQMD in Q1 2022 and held it in 4 quarters. The position peaked at $2.09M in Q4 2022. 8 funds tracked by Wall St. Rank hold IQMD as of Q1 2023.

Picton Mahoney Asset Management reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Picton Mahoney Asset Management sold 203,574 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $2.09M.
Picton Mahoney Asset Management first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 4 quarters.
Picton Mahoney Asset Management's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $2.09M in Q4 2022.
8 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2023, filed 8 May 2023.